April 4, 2018 / 8:30 PM / 19 days ago

BRIEF-Eleven Biotherapeutics Reports Q4 Loss Per Share $0.22

April 4 (Reuters) - Eleven Biotherapeutics Inc:

* ELEVEN BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 OPERATING RESULTS AND VICINIUM DEVELOPMENT PROGRESS

* Q4 LOSS PER SHARE $0.22

* ELEVEN BIOTHERAPEUTICS - NO REV WAS RECOGNIZED DURING QTR ENDED DEC. 31, 2017 VS $0.8 MLN FOR SAME THREE-MONTH PERIOD IN 2016

* ELEVEN BIOTHERAPEUTICS INC - EXPECTS TO HAVE CAPITAL TO FUND CURRENT OPERATING PLANS INTO Q1 2019

* ELEVEN BIOTHERAPEUTICS INC - CASH AND CASH EQUIVALENTS WERE $14.7 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below